Benzinga's Top Pre-Market Gainers

Supernus Pharmaceuticals (NASDAQ: SUPN ) moved up 26.51% to $8.40 in the pre-market session after the company received final approval from the FDA for Trokendi XR. Partner Communications Company (NASDAQ: PTNR ) soared 3.75% to $8.02 in the pre-market trading. Partner Communications is expected to report its reviewed financial